The 2026 American Diabetes Association (ADA) national conference was intended to be a watershed moment for the...
Chemotherapy and Targeted Therapy
Since its inception in June 2025, the FDA’s Commissioner’s National Priority Voucher (CNPV) pilot program has become...
By Industry Desk Published July 1, 2026 In a significant development for the inflammatory bowel disease (IBD)...
In the high-stakes theater of precision oncology, Swiss pharmaceutical titan Roche is making a calculated move to...
By Jonathan Gardner | Published June 30, 2026 The U.S. Food and Drug Administration (FDA) is grappling...
By Gwendolyn Wu | Updated June 30, 2026 In a significant vote of confidence for the "spin-out"...
The global healthcare industry, often viewed as a beacon of human progress and life-saving innovation, is grappling...
The landscape of metabolic medicine is undergoing a profound transformation. Since the landmark approval of the first...
The U.S. pharmaceutical landscape is undergoing a structural metamorphosis. As regulatory pressure mounts to curb soaring healthcare...
Traumatic brain injury (TBI) is not merely an acute mechanical event; for millions, it is the starting...
